CPEX Insider Trading Activity and SEC Form 4 Filings
CPEX insider trading summary
No open-market insider purchases or sales of CPEX Pharmaceuticals, Inc. (CPEX) have been reported on SEC Form 4 in the past 12 months.
Latest CPEX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 16, 2010 | Arcadia Capital Advisors, LLC | 10% Owner | Sell | $789K (50,109 @ $15.74) |
| Feb 16, 2010 | MD Sass Finstrat Arcadia Capital Holdings, LLC | 10% Owner | Sell | $789K (50,109 @ $15.74) |
| Feb 16, 2010 | James S Frank | 10% Owner | Sell | $789K (50,109 @ $15.74) |
| Feb 16, 2010 | Arcadia Opportunity Master Fund, LTD | 10% Owner | Sell | $789K (50,109 @ $15.74) |
| Feb 16, 2010 | Richard S Rofe | 10% Owner | Sell | $789K (50,109 @ $15.74) |
| Feb 12, 2010 | James S Frank | 10% Owner | Sell | $45K (2,820 @ $16.07) |
| Feb 12, 2010 | Arcadia Opportunity Master Fund, LTD | 10% Owner | Sell | $45K (2,820 @ $16.07) |
| Feb 12, 2010 | Richard S Rofe | 10% Owner | Sell | $45K (2,820 @ $16.07) |
| Feb 12, 2010 | MD Sass Finstrat Arcadia Capital Holdings, LLC | 10% Owner | Sell | $45K (2,820 @ $16.07) |
| Feb 12, 2010 | Arcadia Capital Advisors, LLC | 10% Owner | Sell | $45K (2,820 @ $16.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.